Back to Search Start Over

Minimal T-Cell-Stimulatory Sequences and Spectrum of HLA Restriction of Immunodominant CD4 + T-Cell Epitopes within Hepatitis C Virus NS3 and NS4 Proteins

Authors :
Reinhart Zachoval
Axel Ulsenheimer
Gerd R. Pape
J. T. Gerlach
R. Zahn
W. Schraut
C.A. Schirren
Maria-Christina Jung
Helmut M. Diepolder
Malte H.J. Heeg
Siegfried Scholz
A. Vogler
K. Witter
Norbert H. Grüner
Source :
Journal of Virology. 79:12425-12433
Publication Year :
2005
Publisher :
American Society for Microbiology, 2005.

Abstract

The hepatitis C virus (HCV)-specific CD4 + T-cell response against nonstructural proteins is strongly associated with successful viral clearance during acute hepatitis C. To further develop these observations into peptide-based vaccines and clinical immunomonitoring tools like HLA class II tetramers, a detailed characterization of immunodominant CD4 + T-cell epitopes is required. We studied peripheral blood mononuclear cells from 20 patients with acute hepatitis C using 83 overlapping 20-mer peptides covering the NS3 helicase and NS4. Eight peptides were recognized by ≥40% of patients, and specific CD4 + T-cell clones were obtained for seven of these and three additional, subdominant epitopes. Mapping of minimal stimulatory sequences defined epitopes of 8 to 13 amino acids in length, but optimal T-cell stimulation was observed with 10- to 15-mers. While some epitopes were presented by different HLA molecules, others were presented by only a single HLA class II molecule, which has implications for patient selection in clinical trials of peptide-based immunotherapies. In conclusion, using two different approaches we identified and characterized a set of CD4 + T-cell epitopes in the HCV NS3-NS4 region which are immunodominant in patients achieving transient or persistent viral control. This information allows the construction of a valuable panel of HCV-specific HLA class II tetramers for further study of CD4 + T-cell responses in chronic hepatitis C. The finding of immunodominant epitopes with very constrained HLA restriction has implications for patient selection in clinical trials of peptide-based immunotherapies.

Details

ISSN :
10985514 and 0022538X
Volume :
79
Database :
OpenAIRE
Journal :
Journal of Virology
Accession number :
edsair.doi.dedup.....5ff6fd2007e8cd7a5aa4fbe6ac552104
Full Text :
https://doi.org/10.1128/jvi.79.19.12425-12433.2005